关注
Ruchi Bansal
Ruchi Bansal
Associate Professor, University of Twente, The Netherlands
在 utwente.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
3D‐bioprinted mini‐brain: a glioblastoma model to study cellular interactions and therapeutics
MA Heinrich, R Bansal, T Lammers, YS Zhang, R Michel Schiffelers, ...
Advanced materials 31 (14), 1806590, 2019
2442019
Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter
V Chaudhuri, R Tayal, B Nayak, SK Acharya, SK Panda
Gastroenterology 127 (5), 1356-1371, 2004
2252004
Therapeutic targeting of hepatic macrophages for the treatment of liver diseases
D van der Heide, R Weiskirchen, R Bansal
Frontiers in immunology 10, 494110, 2019
1992019
Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery
J Schnittert, R Bansal, G Storm, J Prakash
Advanced drug delivery reviews 129, 37-53, 2018
1742018
Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer
K Binnemars‐Postma, R Bansal, G Storm, J Prakash
The FASEB Journal 32 (2), 969-978, 2018
1692018
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
S Yazdani, R Bansal, J Prakash
Advanced drug delivery reviews 121, 101-116, 2017
1602017
Novel engineered targeted interferon‐gamma blocks hepatic fibrogenesis in mice
R Bansal, J Prakash, E Post, L Beljaars, D Schuppan, K Poelstra
Hepatology 54 (2), 586-596, 2011
1252011
Targeting pancreatic stellate cells in cancer
J Schnittert, R Bansal, J Prakash
Trends in cancer 5 (2), 128-142, 2019
1242019
The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis
R Bansal, J Van Baarlen, G Storm, J Prakash
Scientific reports 5 (1), 18272, 2015
1082015
Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles
Q Hu, CJ Rijcken, R Bansal, WE Hennink, G Storm, J Prakash
Biomaterials 53, 370-378, 2015
1062015
Clinical advancements in the targeted therapies against liver fibrosis
R Bansal, B Nagórniewicz, J Prakash
Mediators of inflammation 2016 (1), 7629724, 2016
1052016
Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo
DF Mardhian, G Storm, R Bansal, J Prakash
Journal of controlled release 290, 1-10, 2018
1022018
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
PR Kuninty, R Bansal, SWL De Geus, DF Mardhian, J Schnittert, ...
Science advances 5 (9), eaax2770, 2019
1012019
Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis
F Poosti, R Bansal, S Yazdani, J Prakash, E Post, P Klok, J van den Born, ...
The FASEB Journal 29 (3), 1029-1042, 2015
1002015
Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12
BÖ Akcora, G Storm, R Bansal
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (3), 804-818, 2018
992018
Bioengineered 3D models to recapitulate tissue fibrosis
M Sacchi, R Bansal, J Rouwkema
Trends in biotechnology 38 (6), 623-636, 2020
752020
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases
R Bansal, S Nakagawa, S Yazdani, J Van Baarlen, A Venkatesh, AP Koh, ...
Experimental & molecular medicine 49 (11), e396-e396, 2017
722017
Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis
R Bansal, J Prakash, M Ruijter, L Beljaars, K Poelstra
Molecular pharmaceutics 8 (5), 1899-1909, 2011
722011
Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth
R Bansal, T Tomar, A Östman, K Poelstra, J Prakash
Molecular cancer therapeutics 11 (11), 2419-2428, 2012
642012
Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model
B Öztürk Akcora, G Storm, J Prakash, R Bansal
Scientific reports 7 (1), 44545, 2017
592017
系统目前无法执行此操作,请稍后再试。
文章 1–20